Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848

NCT01185080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: AZD8848
DRUG: Placebo
DRUG: AZD8848 and placebo

Sponsor

AstraZeneca